Brain Cancer Trial, Recruiting NCT07417085 Sponsor: Meyer Children's Hospital IRCCS Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07417085
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 3 and 18 years old who are suspected of having a brain or spinal cord tumour and are scheduled to have brain or spinal surgery.
  • People who have not taken antibiotics or probiotics for a long period of time in the three months before samples are collected for the study.
  • People whose parent or guardian (and the patient where appropriate) has signed a consent form agreeing to take part.

Who may not be able to join:

  • People with a personal history of long-term inflammatory bowel conditions (such as colitis, Crohn's disease, or ulcerative colitis) or certain digestive or intestinal conditions present from birth or developed later (such as coeliac disease, diverticulitis, peritonitis, Hirschsprung's disease, short bowel syndrome, intestinal malrotation or duplication, intestinal blockages, omphalocele, a stoma, or recent severe gastroenteritis).
  • People who have previously received treatments related to cancer (such as chemotherapy or radiation) (confirm with trial site).
  • People whose brain tumour diagnosis has not been confirmed by laboratory analysis of tissue removed during surgery — this means the diagnosis must be verified after the operation before this criterion can be fully assessed (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Meyer Children's Hospital IRCCS
Registry
ClinicalTrials.gov
Start date
6 February 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in the composition of the microbiota

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov